~~<i id='0E7B15FDE2'><strike id='0E7B15FDE2'><tt id='0E7B15FDE2'><pre id='0E7B15FDE2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：hotspot 2025-09-27 12:56:46 - browse：24485

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Medicare threatens to cut off funding for HCA's Mission hospital

Wikipedia

explore

leisure time

focus

entertainment

knowledge

AdobeMedicaidisanessentialsourceofmaternalandpostpartumcareforlow-incomeAmericans,covering42%ofbirth

WSS

A public scorecard can help hold safety

A public scorecard can help hold safety

Listen: Wegovy in the brain & pivotal Alzheimer's data

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Sanofi seeks simpler, safer CRISPR sickle cell cure

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

hotspot

leisure time

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

KalVista pill reduced swelling 'attacks' caused by genetic disease

Sports medicine is finally prioritizing gender equality

Custom gene therapy hints at new path for rare disease treatments

The cancer drug shortage isn’t new — and neither are the solutions

AI can’t replace a physician’s gut feeling

Malaria cases in Florida and Texas: Here’s what you need to know

To avoid data mishandling cases, universities eye AI and other tools

Bright Health sells Medicare Advantage business to Molina

PhRMA lawsuit over Medicare drug price negotiation tossed

explore

How Medicaid coverage policies for immigrants impact new moms

FDA approves RSV monoclonal antibody for infants, toddlers

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

What we’ve learned from the Aduhelm mess

Biden tests positive for Covid

Medicare Advantage proposed rates disappoint insurers

leisure time

focus

entertainment

knowledge